利西拉来/320367-13-3；827033-10-3；1997361-87-1（Hac）/Lixisenatide

Product Name：Lixisenatide

CAS No.：320367-13-3；827033-10-3；1997361-87-1（Hac）

Synonyms：利西拉来

Catalog No.：218P139

Brand：Typeptide Biotech（肽研生物）

Description：Lixisenatide是目前用于治疗糖尿病的药物，并且也是GLP-1的受体激动剂，序列中含有44个氨基酸，是一条碱性多肽。Lixisenatide于2013年在欧洲获得上市批准，以Lixisenatide为主要原料的药物属注射用糖尿病治疗药物，一天注射一次，连同其它药物或者胰岛素一块使用，适用于只能通过药物来控制血糖水平的患者。本公司生产的是多肽产品非成品药。

Lixisenatide is currently used to treat diabetes and is also a receptor agonist of GLP-1. It contains 44 amino acids in its sequence and is a basic polypeptide. Lixisenatide was approved for marketing in Europe in 2013. The drug with Lixisenatide as the main raw material is a drug for diabetes injection. It is injected once a day and used together with other drugs or insulin. It is applicable to patients who can only control the blood sugar level through drugs. Our company produces peptide products that are not finished drugs.

Purity (HPLC) ≥98.0%

Single impurity≤2%

Peptide content≥75.0%

Amino Acid Composition≤±15%

Bacterial Endotoxins≤50EU/mg

Solubility：H₂O/DMSO

Vacuum-packed with aluminum foil bag or transparent bag.Various weights can be packed according to your requirements.

Storage:Cool dry place( Store at -20°C, away from the light)

Remark:For Research Use Only. Not for human use.

订购联系方式：

南京肽研生物生物科技有限公司

手机号：19961912513(微信同号)

QQ: 2178255659

邮箱：sales@typeptide.com

联系人：顾经理

申明：本产品仅供科研使用，不得用于人体。